Literature DB >> 19915792

Taurine inhibits osteoclastogenesis through the taurine transporter.

Ling-Qing Yuan1, Wei Liu, Rong-Rong Cui, Dan Wang, Ji-Cai Meng, Hui Xie, Xian-Ping Wu, Hou-De Zhou, Ying Lu, Er-Yuan Liao.   

Abstract

Several studies have suggested a direct link between taurine and bone homeostasis. However, the mechanisms of taurine on the regulation of bone metabolism have not been elucidated. Using a coculture of osteoblasts and bone marrow cells as a model for the study of osteoclastogenesis, RANKL-stimulated RAW264.7 cells and M-CSF- and RANKL-induced bone marrow macrophages were investigated to elucidate the possible roles of taurine in osteoclastogenesis. Taurine inhibited osteoclastogenesis in the coculture of osteoblasts and bone marrow cells, but did not influence the expression of OPG and RANKL in osteoblasts. The taurine transporter (TAUT) expressed by RAW264.7 and bone marrow macrophages exhibited typical taurine uptake activity. Taurine directly reduced osteoclastogenesis in RANKL-stimulated RAW264.7 cells and M-CSF- and RANKL-induced bone marrow macrophages, while TAUT siRNA relieved this effect. Our study demonstrated that taurine directly inhibited osteoclastogenesis through the taurine transporter. Taken together, these data suggest that taurine plays a direct role in bone homeostasis by inhibiting osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915792     DOI: 10.1007/s00726-009-0380-2

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

1.  Taurine and brain development: trophic or cytoprotective actions?

Authors:  Herminia Pasantes-Morales; Reyna Hernández-Benítez
Journal:  Neurochem Res       Date:  2010-09-15       Impact factor: 3.996

Review 2.  Metabolomic biomarkers of low BMD: a systematic review.

Authors:  N Panahi; B Arjmand; A Ostovar; E Kouhestani; R Heshmat; A Soltani; B Larijani
Journal:  Osteoporos Int       Date:  2021-07-26       Impact factor: 4.507

3.  Taurine, an osteocyte metabolite, protects against oxidative stress-induced cell death and decreases inhibitors of the Wnt/β-catenin signaling pathway.

Authors:  M Prideaux; Y Kitase; M Kimble; T M O'Connell; L F Bonewald
Journal:  Bone       Date:  2020-04-21       Impact factor: 4.398

Review 4.  Protein/amino-acid modulation of bone cell function.

Authors:  Robert MacDonell; Mark W Hamrick; Carlos M Isales
Journal:  Bonekey Rep       Date:  2016-08-10

5.  Protective Effects of Vitamin K Compounds on the Proteomic Profile of Osteoblasts under Oxidative Stress Conditions.

Authors:  Marta Muszyńska; Ewa Ambrożewicz; Agnieszka Gęgotek; Grzegorz Grynkiewicz; Elżbieta Skrzydlewska
Journal:  Molecules       Date:  2020-04-23       Impact factor: 4.411

Review 6.  A Key Metabolic Regulator of Bone and Cartilage Health.

Authors:  Elizabeth Pérez-Hernández; Jesús Javier Pastrana-Carballo; Fernando Gómez-Chávez; Ramesh C Gupta; Nury Pérez-Hernández
Journal:  Endocrinol Metab (Seoul)       Date:  2022-08-08

7.  Puerarin Suppress Apoptosis of Human Osteoblasts via ERK Signaling Pathway.

Authors:  Ling-Juan Liu; Li-Qun Liu; Tao Bo; Shi-Jun Li; Zhen Zhu; Rong-Rong Cui; Ding-An Mao
Journal:  Int J Endocrinol       Date:  2013-06-12       Impact factor: 3.257

8.  Taurine Activates BMP-2/Wnt3a-Mediated Osteoblast Differentiation and Mineralization via Akt and MAPK Signaling.

Authors:  Minsu Park; Hyeon Kyeong Choi; Jeung Hee An
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.